Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

41 ta ish

Ish: Ways to overcome difficulties in diagnosing non-alcoholic fatty liver disease

  1. Non-coding RNA regulatory networks

    Simona Panni, Ruth C. Lovering, Pablo Porras +1

    Sharh maqola20195 iqtibos
    ABI

  2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

    Zobair M. Younossi, Quentin M. Anstee, M. Marietti +5

    Sharh maqolaOchiq kirish20174 iqtibos
    ABI

  3. NAFLD: Mechanisms, Treatments, and Biomarkers

    Fatiha Nassir

    Sharh maqola20224 iqtibos
    ABI

  4. Mechanisms of NAFLD development and therapeutic strategies

    Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella +1

    Sharh maqola20184 iqtibos
    ABI

  5. Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms

    Luca Valenti, Anna Alisi, Valério Nobili

    Boshqa20123 iqtibos
    ABI

  6. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent

    Stefano Romeo, Federica Sentinelli, Satya Dash +9

    Maqola20093 iqtibos
    ABI

  7. Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea

    Sang Soo Lee, Young-Sang Byoun, Sook‐Hyang Jeong +4

    Maqola20143 iqtibos
    ABI

  8. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies

    Ahmad Al‐Serri, Quentin M. Anstee, Luca Valenti +8

    Maqola20113 iqtibos
    ABI

  9. Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase

    Manju Kumari, Gabriele Schoiswohl, Chandramohan Chitraju +18

    Maqola20123 iqtibos
    ABI

  10. Nonalcoholic fatty liver disease: What do we know and what will we have to learn?

    Н. И. Волкова, Maria Porksheyan

    Sharh maqola20173 iqtibos
    ABI

  11. NASH in Lean Individuals

    Ramy Younes, Elisabetta Bugianesi

    Sharh maqola20193 iqtibos
    ABI

  12. Diagnosis and management of non-alcoholic fatty liver disease

    Erica Jennison, Janisha Patel, Eleonora Scorletti +1

    Sharh maqola20193 iqtibos
    ABI

  13. Epidemiology of chronic liver diseases in the USA in the past three decades

    Zobair M. Younossi, Maria Stepanova, Youssef Younossi +4

    Maqola20193 iqtibos
    ABI

  14. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers

    Olfa Khalifa, Khaoula Errafii‬, Nayla S. Al-Akl +1

    Sharh maqola20203 iqtibos
    ABI

  15. MM-associated circular RNA downregulates microRNA-19a through methylation to suppress proliferation of pancreatic adenocarcinoma cells

    Xinye Qian, Wenru Zong, Liqing Ma +4

    Maqola20223 iqtibos
    ABI

  16. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease

    Thomas G. Cotter, Mary E. Rinella

    Sharh maqola20202 iqtibos
    ABI

  17. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study

    Rohit Loomba, Tanya Wolfson, Brandon Ang +9

    Maqola20142 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI